Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 4/5

Avrobio Inc (AVRO US)

2
Analysis
Health CareUnited States
Avrobio, Inc. operates as a bio-technology company. The Company develops step-change cell and gene therapies for the treatment of cancer and rare disease. Avrobio serves clients in the United States and Canada.
more
bullishAvrobio Inc
01 Feb 2024 22:45Syndicated

Some updates

From what I have read from people more knowledgeable about biotechs, they have some promising treatments in development with pretty impressive...

Share
bullishI-Mab
03 Jan 2024 23:10Syndicated

Quick Ideas #6

First of all, happy new year to all my readers! May 2024 bring market beating returns for everyone. Again I managed to underperform my blog stock...

Share
No more insights
x